Hollsteen
← Microchip

Equity incl. NCI

Balance – as of period end · $M

QuartersFiscal years

$MEquity incl. NCI · Q1 FY2016: $2.1B · 10-Q 0000827054-15-000134 filed Aug 6, 2015Equity incl. NCI · Q2 FY2016: $2.1B · 10-Q 0000827054-15-000218 filed Nov 9, 2015Equity incl. NCI · Q3 FY2016: $2.1B · 10-Q 0000827054-16-000265 filed Feb 5, 2016Equity incl. NCI · Q4 FY2016: $2.2B · 10-K 0000827054-16-000344 filed May 24, 2016Equity incl. NCI · Q1 FY2017: $2.5B · 10-Q 0000827054-16-000385 filed Aug 9, 2016Equity incl. NCI · Q2 FY2017: $2.5B · 10-Q 0000827054-16-000472 filed Nov 8, 2016Equity incl. NCI · Q3 FY2017: $2.6B · 10-Q 0000827054-17-000018 filed Feb 8, 2017Equity incl. NCI · Q4 FY2017: $3.3B · 10-K 0001628280-18-006982 filed May 18, 2018Equity incl. NCI · Q1 FY2018: $3.4B · 10-Q 0000827054-17-000132 filed Aug 4, 2017Equity incl. NCI · Q2 FY2018: $3.5B · 10-Q 0000827054-17-000203 filed Nov 7, 2017Equity incl. NCI · Q3 FY2018: $3.2B · 10-Q 0000827054-18-000021 filed Feb 7, 2018Equity incl. NCI · Q4 FY2018: $3.3B · 10-K 0001628280-18-006982 filed May 18, 2018Equity incl. NCI · Q1 FY2019: $5.1B · 10-Q 0000827054-18-000143 filed Aug 9, 2018Equity incl. NCI · Q2 FY2019: $5.2B · 10-Q 0000827054-18-000249 filed Nov 7, 2018Equity incl. NCI · Q3 FY2019: $5.2B · 10-Q 0000827054-19-000018 filed Feb 6, 2019Equity incl. NCI · Q4 FY2019: $5.3B · 10-K 0000827054-19-000143 filed May 30, 2019Equity incl. NCI · Q1 FY2020: $5.3B · 10-Q 0000827054-19-000197 filed Aug 7, 2019Equity incl. NCI · Q2 FY2020: $5.4B · 10-Q 0000827054-19-000288 filed Nov 6, 2019Equity incl. NCI · Q3 FY2020: $5.6B · 10-Q 0000827054-20-000029 filed Feb 4, 2020Equity incl. NCI · Q4 FY2020: $5.6B · 10-K 0000827054-20-000119 filed May 22, 2020Equity incl. NCI · Q1 FY2021: $5.5B · 10-Q 0000827054-20-000186 filed Aug 4, 2020Equity incl. NCI · Q2 FY2021: $5.4B · 10-Q 0000827054-20-000278 filed Nov 5, 2020Equity incl. NCI · Q3 FY2021: $5.3B · 10-Q 0000827054-21-000025 filed Feb 4, 2021Equity incl. NCI · Q4 FY2021: $5.3B · 10-K 0000827054-21-000106 filed May 18, 2021Equity incl. NCI · Q1 FY2022: $5.5B · 10-Q 0000827054-21-000187 filed Aug 3, 2021Equity incl. NCI · Q2 FY2022: $5.7B · 10-Q 0000827054-21-000280 filed Nov 4, 2021Equity incl. NCI · Q3 FY2022: $5.8B · 10-Q 0000827054-22-000025 filed Feb 3, 2022Equity incl. NCI · Q4 FY2022: $5.9B · 10-K 0000827054-22-000094 filed May 20, 2022Equity incl. NCI · Q1 FY2023: $6.0B · 10-Q 0000827054-22-000148 filed Aug 2, 2022Equity incl. NCI · Q2 FY2023: $6.1B · 10-Q 0000827054-22-000193 filed Nov 3, 2022Equity incl. NCI · Q3 FY2023: $6.3B · 10-Q 0000827054-23-000020 filed Feb 2, 2023Equity incl. NCI · Q4 FY2023: $6.5B · 10-K 0000827054-23-000080 filed May 25, 2023Equity incl. NCI · Q1 FY2024: $6.8B · 10-Q 0000827054-23-000132 filed Aug 3, 2023Equity incl. NCI · Q2 FY2024: $7.0B · 10-Q 0000827054-23-000185 filed Nov 2, 2023Equity incl. NCI · Q3 FY2024: $7.1B · 10-Q 0000827054-24-000024 filed Feb 1, 2024Equity incl. NCI · Q4 FY2024: $6.7B · 10-K 0000827054-24-000098 filed May 23, 2024Equity incl. NCI · Q1 FY2025: $6.4B · 10-Q 0000827054-24-000139 filed Aug 1, 2024Equity incl. NCI · Q2 FY2025: $6.3B · 10-Q 0000827054-24-000206 filed Nov 5, 2024Equity incl. NCI · Q3 FY2025: $6.0B · 10-Q 0000827054-25-000019 filed Feb 6, 2025Equity incl. NCI · Q4 FY2025: $7.1B · 10-K 0000827054-25-000077 filed May 23, 2025Equity incl. NCI · Q1 FY2026: $6.9B · 10-Q 0000827054-25-000133 filed Aug 7, 2025Equity incl. NCI · Q2 FY2026: $6.7B · 10-Q 0000827054-25-000183 filed Nov 6, 2025Equity incl. NCI · Q3 FY2026: $6.6B · 10-Q 0000827054-26-000009 filed Feb 5, 2026Equity incl. NCI · Q4 FY2026: $6.4B · 10-K 0000827054-26-000016 filed May 21, 2026Equity incl. NCI · Q1 FY2027: $6.5B · 10-Q 0000827054-26-000038 filed Aug 6, 20266,3126,4512,0997,080Q1 FY2016Q1 FY2027Q3 FY2023
$MEquity incl. NCI · Q3 FY2022: $5.8B · 10-Q 0000827054-22-000025 filed Feb 3, 2022Equity incl. NCI · Q4 FY2022: $5.9B · 10-K 0000827054-22-000094 filed May 20, 2022Equity incl. NCI · Q1 FY2023: $6.0B · 10-Q 0000827054-22-000148 filed Aug 2, 2022Equity incl. NCI · Q2 FY2023: $6.1B · 10-Q 0000827054-22-000193 filed Nov 3, 2022Equity incl. NCI · Q3 FY2023: $6.3B · 10-Q 0000827054-23-000020 filed Feb 2, 2023Equity incl. NCI · Q4 FY2023: $6.5B · 10-K 0000827054-23-000080 filed May 25, 2023Equity incl. NCI · Q1 FY2024: $6.8B · 10-Q 0000827054-23-000132 filed Aug 3, 2023Equity incl. NCI · Q2 FY2024: $7.0B · 10-Q 0000827054-23-000185 filed Nov 2, 20236,3126,9685,803Q3 FY2022Q2 FY2024Q3 FY2023
Q3 FY2023
6,312$M
All values (45)
PeriodValue ($M)Status
Q1 FY20276,451reported
Q4 FY20266,432reported
Q3 FY20266,560reported
Q2 FY20266,696reported
Q1 FY20266,857reported
Q4 FY20257,078reported
Q3 FY20256,032reported
Q2 FY20256,276reported
Q1 FY20256,406reported
Q4 FY20246,658reported
Q3 FY20247,080reported
Q2 FY20246,968reported
Q1 FY20246,831reported
Q4 FY20236,514reported
Q3 FY20236,312reported
Q2 FY20236,103reported
Q1 FY20235,978reported
Q4 FY20225,895reported
Q3 FY20225,803reported
Q2 FY20225,703reported
Q1 FY20225,520reported
Q4 FY20215,337reported
Q3 FY20215,297reported
Q2 FY20215,444reported
Q1 FY20215,501reported
Q4 FY20205,586reported
Q3 FY20205,617reported
Q2 FY20205,361reported
Q1 FY20205,288reported
Q4 FY20195,288reported
Q3 FY20195,161reported
Q2 FY20195,170reported
Q1 FY20195,124reported
Q4 FY20183,280reported
Q3 FY20183,185reported
Q2 FY20183,546reported
Q1 FY20183,413reported
Q4 FY20173,271reported
Q3 FY20172,567reported
Q2 FY20172,520reported
Q1 FY20172,533reported
Q4 FY20162,151reported
Q3 FY20162,126reported
Q2 FY20162,129reported
Q1 FY20162,099reported

CSV with all sources · Technical ID: equity_total

More metrics for Microchip

Income statement

Per share

Balance sheet

Cash flow

Debt and interest

Revenue by segment/product/region

Gross profit by segment

Sources & calculation
Value
$6.3B
Period
Q3 FY2023, ended Dec 31, 2022 · as of Dec 31, 2022 (balance as of date, not a sum)
Source
10-Q, filed Feb 2, 2023 · 0000827054-23-000020
Location
us-gaap:StockholdersEquity
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)

Versions

v1$6.3BFeb 2, 202310-Q 0000827054-23-000020reported · confidence 1. · current